Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022560

CHIEF OPERATING OFFICER sold 17,500 shares at $26.91 ($470,925)

  • CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2024-08-27 Option exercise 10b5-1 +10,000 $1.59 $15,900 137,411 D
Tessari Eben CHIEF OPERATING OFFICER 2024-08-27 Sale 10b5-1 −17,500 $26.91 $470,925 119,911 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2024-08-27 Option exercise · Share Option 10b5-1 −10,000 46,017 D
Open-market sales · 17,500 sh · avg $26.91 · $470,925
Loading xslF345X05/form4-08292024_080838.xml…